Inmunidad de las Mucosas y Alergia: de la Inmunopatología a la Terapia.
Consorci Sanitari de Terrassa
Terrassa, EspañaPublications en collaboration avec des chercheurs de Consorci Sanitari de Terrassa (6)
2024
-
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290
-
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics, Vol. 16, Núm. 5
2021
-
Persistent Villous Atrophy in De Novo Adult Patients With Celiac Disease and Strict Control of Gluten-Free Diet Adherence: A Multicenter Prospective Study (CADER Study)
The American journal of gastroenterology, Vol. 116, Núm. 5, pp. 1036-1043
2016
-
Incidence, clinical characteristics, and management of psoriasis induced by Anti-TNF therapy in patients with inflammatory bowel disease: A nationwide cohort study
Inflammatory Bowel Diseases, Vol. 22, Núm. 4, pp. 894-901
2015
-
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
Alimentary Pharmacology and Therapeutics, Vol. 41, Núm. 8, pp. 768-775
2014
-
Risk of colectomy in patients with ulcerative colitis under thiopurine treatment
Journal of Crohn's and Colitis, Vol. 8, Núm. 10, pp. 1287-1293